Barclays’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-9,800
Closed -$277K 7352
2018
Q2
$277K Buy
+9,800
New +$349K ﹤0.01% 4449
2016
Q4
Sell
-40
Closed -$1K 6809
2016
Q3
$1K Sell
40
-500
-93% -$14.3K ﹤0.01% 6426
2016
Q2
$12K Buy
+540
New +$13.4K ﹤0.01% 5479
2015
Q3
Sell
-1,010
Closed -$30K 7018
2015
Q2
$30K Buy
1,010
+970
+2,425% +$37.1K ﹤0.01% 5443
2015
Q1
$1K Buy
+40
New +$1.1K ﹤0.01% 6987
2014
Q4
Sell
-300
Closed -$3K 7554
2014
Q3
$3K Sell
300
-130
-30% -$3.67K ﹤0.01% 7325
2014
Q2
$13K Sell
430
-1,210
-74% -$41.1K ﹤0.01% 6706
2014
Q1
$49K Buy
1,640
+1,420
+645% +$50.6K ﹤0.01% 6016
2013
Q4
$4K Sell
220
-1,490
-87% -$43.7K ﹤0.01% 7221
2013
Q3
$51K Sell
1,710
-230
-12% -$8.39K ﹤0.01% 6052
2013
Q2
$65K Buy
+1,940
New +$87.9K ﹤0.01% 6117

Other funds holding RIGL